We can speculate that low expression of ICOSL in the primary tumor might favor detachment of tumor cells, their survival in the blood stream, and their extravasation at the metastatic site, since these cells would be less sensitive to the dominant negative inhibition triggered by ICOS. This evidence concerns the gene ICOS and neoplasm.